Published in Drug Week, March 16th, 2012
"LC-MS/MS methods using signature peptides are emerging as an alternative approach, which typically use a stable...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2012-03-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.